Drug Shortage Report for MYLAN-ESOMEPRAZOLE

Last updated on 2018-03-01 History
Report ID 33989
Drug Identification Number 02383047
Brand name MYLAN-ESOMEPRAZOLE
Common or Proper name ESOMEPRAZOLE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) ESOMEPRAZOLE
Strength(s) 40MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL
Packaging size 100 BT
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-02-12
Actual start date 2018-01-12
Estimated end date 2018-03-02
Actual end date 2018-02-28
Shortage status Resolved
Updated date 2018-03-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v42 2018-03-01 English Compare
v41 2018-02-28 French Compare
v40 2018-02-28 English Compare
v39 2018-02-27 French Compare
v38 2018-02-27 English Compare
v37 2018-02-23 French Compare
v36 2018-02-23 English Compare
v35 2018-02-12 French Compare
v34 2018-02-12 English Compare
v33 2018-02-09 French Compare
v32 2018-02-09 English Compare
v31 2018-02-08 French Compare
v30 2018-02-08 English Compare
v29 2018-02-02 French Compare
v28 2018-02-02 English Compare
v27 2018-01-31 French Compare
v26 2018-01-31 English Compare
v25 2018-01-26 French Compare
v24 2018-01-26 English Compare
v23 2018-01-24 French Compare

Showing 1 to 20 of 42